Ablation has gained immense popularity around the world because it provides a minimally invasive solution for removing tissues and tumors with acceptable pain and shorter recovery times compared to open surgery. Demand for ablation devices is expected to increase worldwide due to an increasing incidence of chronic diseases, primarily tumorigenic cancers and other cardiovascular diseases. According to the World Health Organization (WHO), chronic disease is the leading cause of death, killing more than 38 million people worldwide in 2015.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/464
In addition, according to WHO, cancer was one of the leading causes of death in 2015, killing up to 8.8 million people. According to the Centers for Disease Control and Prevention (CDC), an estimated 2.7 to 6.1 million people in the U.S. suffered from atrial fibrillation in 2016. The same report states that about 2% of people under the age of 65 are affected by atrial fibrillation. Ablation is the process of removing certain biological substances from the inside of the body with the help of ablation equipment through a variety of techniques such as vaporization, laser, heat treatment, cryogenic treatment, and radiation therapy. In the medical field, ablation is usually done by a surgical procedure to remove biological material such as small tumors. Other techniques used to remove infected tissue include chemical excision and radiofrequency excision.
The global ablation devices market is estimated to be US$ 4,290.8 million in 2019 and is expected to show a CAGR of 10.9% during the forecast period (2019-2027).
Increased launches of products are expected to boost the growth of the global ablation device market.
The high prevalence of such diseases is expected to drive the growth of the global ablation devices market.
Various companies are focusing on introducing innovative and technologically advanced products to meet consumer demand. In 2016, Medtronic launched the new Barrx 360 Express High Frequency Ablation (RFA) Balloon Catheter for the treatment of Barrett’s esophagus.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/464
Growth in the global ablation devices market is expected to be hampered during the forecast period by increased FDA recalls. In November 2018, the U.S. Food and Drug Administration (FDA) exchanged resin subcontractors three times without notifying Boston Scientific Corporation, resulting in a percutaneous development developed by Boston Scientific Corporation as part of a Class 3 device recall. The cardiac ablation catheter was recalled.
North America dominates the global ablation devices market due to the increasing adoption of ablation systems. 2016, Medtronic Plc. Launched Osteo Cool, a radiofrequency ablation system in the United States. OsteoCool RF Ablation System is a cooled radio frequency (RF) ablation technology. It provides simultaneous dual probe capability for the treatment of painful bone tumors.
Asia Pacific is the fastest growing region of the global ablation devices market due to the increasing prevalence of cancer in the region. According to 2018 cancer statistics, about 2.25 million people live with cancer in India.
Major companies contributing to the global ablation devices market include Johnson & Johnson, Inc., Intuitive Surgical, Inc., Medtronic Plc., Boston Scientific Corporation, Arthrex, Smith & Nephew, AtriCure, Inc., EDAP TMS S.A., Abbott Laboratories, and Halyard Health.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/464
Table of Content
Global Ablation Devices Market Research Report
Section 1: Global Ablation Devices Industry Overview
Section 2: Global Economic Impact on Ablation Devices Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Ablation Devices Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Ablation Devices Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027